Search the courses, subjects, tracks, games and features, or jump straight to a page.
Learn it your way
A short class with Sarah and her students. The other ways are under More.
Sign up free to listen. Transcripts are free to read.
Today, we will discuss non-maleficence, which means 'do no harm.' This is a fundamental principle in bioethics. Can anyone tell me what they think that means?
I think it means we shouldn't hurt anyone with our research.
So, it’s about being careful with technology and making sure it’s safe?
Exactly! Non-maleficence requires us to prevent harm when applying biotechnologies. It's important in all areas, including medicine and agriculture. Remember, the acronym 'DO NO HARM' can help you remember this principle.
Now, let’s explore how non-maleficence impacts biotechnology decisions. For example, in medical biotechnology, how might this principle apply to gene therapy?
We need to make sure it doesn’t cause more health issues than it solves.
And we should test it thoroughly before giving it to patients!
Correct! Thorough testing is vital to minimize unexpected side effects. This highlights ethical responsibilities innovators have to ensure they are upholding non-maleficence. Can someone give an example from agriculture?
GMOs should be studied for health risks before they're released!
Well said! Ensuring safety in GMOs reflects non-maleficence as well.
Let's look at some ethical dilemmas. Can anyone think of a situation in biotechnology where non-maleficence might be challenged?
The Golden Rice example. What if it doesn’t really help reduce blindness as expected?
And what if it causes allergies or health issues?
Both are important considerations! When discussing such innovations, we must weigh potential benefits against possible harm. This engagement with ethical dilemmas is vital in upholding non-maleficence.
To rigorously apply the principle of non-maleficence, we can use ethical decision-making frameworks. What steps might we take?
We could start by identifying the issue and then looking at all the risks.
And then consider how to prevent any harm.
Great! Using such frameworks helps us systematically ensure that we comply with non-maleficence in our decisions. Always remember, considering the potential consequences is essential. What other factors do we need to think about?
We should think about stakeholder opinions as well!
Absolutely! Engaging with stakeholders can provide diverse perspectives that highlight hidden harms.
In biotech and health, we must impart, to do no harm is where we start.
Imagine a scientist developing a new vaccine. They are excited about the innovations and possibilities but realize that every trial must avoid harming any participant. This commitment underscores the essence of non-maleficence.
Remember N.I.C.E – Non-maleficence Implies Careful Evaluation.
N.M. – No Malfunctioning: Ensures all safety and harm assessments are completed.
Term
What is non-maleficence?
Click to flip
Term
Why is non-maleficence important?
Click to flip
Non-maleficence is a key ethical principle in bioethics, emphasizing the obligation to avoid causing harm while engaging in biotechnological practices.
This section elaborates on the principle of non-maleficence, which is fundamental in bioethics. It underscores the importance of preventing harm when utilizing biotechnological innovations and discusses its implications and relevance in real-life bioethical dilemmas.
Non-maleficence is a core ethical principle reflected in the practice of biotechnology and bioethics, encapsulated in the phrase ‘do no harm.’ This principle emphasizes the responsibility of scientists, healthcare providers, and biotechnologists to prevent any potential harm that their innovations and applications may cause to individuals, communities, and the environment. Non-maleficence is paramount in various scenarios within biotechnology, particularly where risks involve genetic modification, medical treatments, and environmental impacts.
In the context of biotechnology, non-maleficence raises significant considerations:
The discussion of non-maleficence also necessitates a broader dialogue about balancing progress with ethical responsibilities as we navigate innovations in the evolving field of biotechnology. The principle serves to guide ethical decision-making, ensuring that stakeholders carefully evaluate potential harms and address them adequately.